# HumaDX

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/humadx

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.humadx.com.cn
- Latest round: Series A (Jun 13, 2023)
- Investors on record: 3

## About

Based in Nanjing, China and founded in 2022, Nanjing Chenguang Medical Technology Co., Ltd. is a medical technology innovation service provider, focusing on a fully automated multi-flow fluorescence platform. The founder, Mr. Li Dongqi worked in National Medical Products Administration before establishing the company. Before working in this company the core team members worked in Beijing Leadman Biochemistry Co., Ltd, Bioscience (Tianjin) Diagnostic Technology Co., Ltd., and other enterprises. The company also has a subsidiary in Beijing. In June 2023, the firm raised an undisclosed amount of series A+ funding from new investors Sunland Capital and Wens Capital. The round was part of a larger CNY 100 million series A funding.

Based on the core technology of multiplex flow fluorescence technology, the company is committed to providing fully automated, high-throughput, and highly competitive multiplex flow fluorescence assay platforms and supporting reagents to clinical customers. The company has launched a fully automated multiplex fluorescence platform and reagents, a fully automated chemiluminescence platform and reagents, and a fully automated immunoblotting platform, and reagents. The products of the company can be used in autoimmune diseases, allergic diseases, cytokines, and thrombosis.

The company will focus on the registration filing of a fully automated multiplex fluorescence detection platform and supporting reagents of the subsidiary, construction of a new production base, and expansion of the research and development team.

## Funding rounds

- Series A, Jun 13, 2023 — Wens Capital, Sunland Capital
- Series A, Jan 4, 2023 — YuanBio Venture

## Investors

- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series A
- Wens Capital (https://capitalatlas.ai/funds/wens-capital) — Series A
- Sunland Capital — Series A